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Abstract
Background: Quantification of myocardial perfusion from first-pass cardiovascular magnetic resonance (CMR) images
at high contrast agent (CA) dose requires separate acquisition of blood pool and myocardial tissue enhancement. In
this study, a dual-sequence approach interleaving 2D imaging of the arterial input function with high-resolution 3D
imaging for myocardial perfusion assessment is presented and validated for low and high CA dose.
Methods: A dual-sequence approach interleaving 2D imaging of the aortic root and 3D imaging of the whole left
ventricle using highly accelerated k-t PCA was implemented. Rest perfusion imaging was performed in ten healthy
volunteers after administration of a Gadolinium-based CA at low (0.025 mmol/kg b.w.) and high dose (0.1 mmol/kg
b.w.). Arterial input functions extracted from the 2D and 3D images were analysed for both doses. Myocardial
contrast-to-noise ratios (CNR) were compared across volunteers and doses. Variations of myocardial perfusion estimates
between volunteers and across myocardial territories were studied.
Results: High CA dose imaging resulted in strong non-linearity of the arterial input function in the 3D images at peak
CA concentration, which was avoided when the input function was derived from the 2D images. Myocardial CNR was
significantly increased at high dose compared to low dose, with a 2.6-fold mean CNR gain. Most robust myocardial
blood flow estimation was achieved using the arterial input function extracted from the 2D image at high CA dose. In
this case, myocardial blood flow estimates varied by 24 % between volunteers and by 20 % between myocardial
territories when analysed on a per-volunteer basis.
Conclusion: Interleaving 2D imaging for arterial input function assessment enables robust quantitative 3D myocardial
perfusion imaging at high CA dose.
Keywords: DCE-MRI, First-pass myocardial perfusion imaging, Arterial input function, Myocardial blood flow estimates,
Dual-sequence imaging
Background
Qualitative assessment and quantitative evaluation of
conventional first-pass perfusion cardiovascular mag-
netic resonance (CMR) is subject to a trade-off pertain-
ing to contrast agent (CA) dosage. While high CA dose
leads to satisfactory myocardial contrast enhancement,
facilitating qualitative discrimination between ischemic
and healthy myocardial tissue [1, 2], it results in pro-
nounced non-linearity between signal intensity and CA
concentration in the blood pool [3, 4]. Accordingly, the
signal enhancement during peak bolus passage is re-
duced, resulting in underestimation of the arterial input
function (AIF) and overestimation of myocardial blood
flow (MBF) estimates [5]. The issue can be addressed by
acquiring the AIF and the myocardial tissue signals with
different time delays after saturation or inversion prepar-
ation [6, 7], or by using a dual-bolus approach [1, 8].
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MBF estimation from first-pass contrast-enhanced
CMR data is based on a linear time-invariant impulse re-
sponse model [9]. Knowledge of both the AIF and the
myocardial signal intensity-time curves is needed to cal-
culate estimates of MBF per unit muscle mass [5]. Con-
ventionally, both the AIF and the myocardial signal
intensity-time curves are extracted from the same CMR
image [5]. The application of low CA dose ensures an
approximately linear relationship between signal inten-
sity and CA concentration, hence facilitating a simple
conversion from signal to concentration. Accordingly,
low CA dose has been advocated for quantitative perfu-
sion CMR. Higher CA dose, however, yields better CNR
resulting in improved detectability of ischemic regions
using qualitative assessment [10]. For a quantitative esti-
mation of MBF, the AIF may be acquired separately
using a low resolution image in conjunction with high-
resolution image data to obtain myocardial signals [6].
Various approaches have been proposed to avoid non-
linearity in the conversion from signal to concentration
while exploiting the benefits of high CA dose. All
methods proposed so far are based on either a reduction
of the dose for the AIF acquisition or modification of
the time between magnetization preparation and im-
aging, e.g. the saturation recovery time in case of satur-
ation preparation. Dual-bolus approaches employ a low
dose bolus for the AIF measurement in a separate scan
followed by a higher dose to obtain the myocardial resi-
due curves [1, 8, 11]. Dual-sequence methods use two
interleaved imaging sequences to acquire the AIF and
tissue residue concurrently from the same CA bolus
[6, 7, 12]. An alternative sequence-based approach is
the use of radial trajectories and reconstruction of
separate images for blood pool and myocardial en-
hancement from different amounts of projections in
the same dataset [13–15]. While the dual-bolus ap-
proach results in increased overall scan times and the
administration of multiple CA injections adds to the
complexity of the exam, examination time and CA
setup are not changed in the dual-sequence approach.
Accordingly, the dual-sequence approach is preferred
and considered suited for wider clinical adoption.
In order to address the limited cardiac coverage of
two-dimensional (2D) multi-slice myocardial perfusion
CMR techniques, three-dimensional (3D) methods have
been developed based on scan acceleration methodology
[16–19]. Recent multi-centre data have confirmed the
diagnostic accuracy of 3D CMR perfusion imaging [20,
21], and quantification of the percentage of ischemic
myocardium by direct volumetry has been demon-
strated [20, 22, 23]. Since ischemic burden above
10 % is increasingly used as a marker for decision
making as to the need for revascularization [24], 3D
CMR perfusion imaging is expected to play an
important role as a technique for the diagnosis of
stable coronary artery disease. The added value of de-
riving quantitative MBF estimates from CMR data has
also been emphasized in the context of triple vessel
coronary artery disease [25] and syndrome X [26],
and the feasibility of whole-heart MBF estimation
from 3D CMR perfusion images has recently been re-
ported [27].
The present study introduces a dual-sequence ap-
proach interleaving 3D high-resolution myocardial per-
fusion imaging and 2D low-resolution AIF acquisition
for high dose first-pass perfusion imaging with whole-
heart coverage. Using in-vivo data obtained in healthy
volunteers at rest it is demonstrated that the sequence
allows for improved AIF assessment and hence improved
MBF estimation.
Methods
A dynamically interleaved 2D/3D dual-sequence scheme
was implemented in a dedicated acquisition framework
[28]. All images were acquired on a 1.5 T Philips Achieva
MR system (Philips Healthcare, Best, The Netherlands)
using a 5-element cardiac receive coil array. Interleaved
acquisitions consisted of electrocardiogram (ECG) trig-
gered saturation-recovery spoiled gradient echo sequences
using spatiotemporal k-t undersampling. Gadobutrol
(Gadovist, Bayer Schering Pharma, Germany) was used as
contrast agent (CA).
Phantom measurements
Saline phantoms doped with variable amounts of CA
were built. CA concentrations varied from 0 to 5 mmol/l.
Using the relationship between T1 and concentration c,
1
T1
¼ 1
T 1;0
þ c⋅R ð1Þ
with CA relaxivity R ¼ 5:2 l=mmol⋅s [29] and T1,0 =
1200 ms at baseline in the absence of CA [30], peak con-
centration corresponded to T1 = 37 ms. This value is in
line with previous studies, where blood pool T1 values at
peak bolus between 30 and 50 ms were reported [6, 12].
Phantoms were measured using saturation recovery
delays of 30 and 150 ms to investigate the relationship
between signal intensity and concentration. For the 2D-
AIF sequence the signal to concentration linearity must
be approximately valid in the blood pool at peak en-
hancement, hence a short saturation delay is required.
For the 3D acquisition, the linearity must hold for the
myocardial tissue only, where the expected T1 is above
200 ms [12], thus enabling longer saturation delays.
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In-vivo experiments
Ten healthy volunteers (5 male) with an average age (±
standard deviation) of 25.7 ± 5.1 years underwent first-
pass rest perfusion CMR examinations. All volunteers
were scanned upon written informed consent according
to local ethics regulations. Two contrast-enhanced dual-
sequence imaging experiments were run using CA bo-
luses at doses of 0.025 and 0.1 mmol/kg b.w. to compare
low and high dose imaging. CA was injected at 4 ml/s
and followed by a 30 ml saline flush at the same rate
using a power injector (Medrad, Indianola, PA, USA).
Twenty minutes were allowed for CA washout in-
between the two bolus injections; low CA dose imaging
was always performed first. Image acquisition covered
30 heartbeats during a single breath-hold.
Acquisition comprised ECG-triggered saturation-
recovery spoiled gradient echo sequences with individual
WET saturation preparation [31] played out in an inter-
leaved fashion within each heartbeat, as shown in Fig. 1.
3D imaging was triggered to end systole and employed
10-fold Cartesian k-t undersampling [17, 32]. Ten con-
tiguous short-axis slices were acquired using 75 % partial
Fourier sampling in frequency-encode and both phase-
encode directions. Elliptical k-space shutters were ap-
plied on the undersampling pattern as well as on the
fully sampled 11x7 central k-space training matrix. The
net undersampling factor was 7.1-8.2 depending on the
field-of-view. Including partial Fourier sampling and k-
space shutters, acceleration factors were between 12.2
and 15.2 when compared to a fully sampled Cartesian
scan. 3D imaging parameters were: repetition time (TR):
2–2.2 ms, echo time (TE): 0.78-0.95 ms, spatial reso-
lution: 2.0x2.0x10 mm3, flip angle: 15°, acquisition
window: 226–309 ms, and saturation delay: 150 ms.
Transverse 2D images were acquired in the ascending
aorta. A diastolic time frame after aortic valve closure,
identified using a 3-chamber cine scan, was selected
for 2D imaging to avoid inflow effects [33]. Three-fold k-
t undersampling with 11 training profiles was applied.
2D acquisition parameters were: spatial resolution:
3.5x3.5 mm2, slice thickness: 10 mm, flip angle: 15°, ac-
quisition window: 56–64 ms, saturation delay: 30 ms,
and 75 % partial Fourier sampling in kx and ky. TR and
TE were equal to the corresponding 3D image. Figure 2
illustrates typical scan planning for the interleaved 2D/
3D measurement.
Image reconstruction and signal comparison
Image reconstruction was performed using ReconFrame
(Gyrotools LLC, Zurich, Switzerland). Subsequent post-
processing was implemented in Matlab (The Math-
Works, Natick, MA, USA). Image reconstruction was
performed using k-t principal component analysis
(k-t PCA) [34] with a separate sensitivity reference
scan for coil sensitivity map calculation. Zero-filling
was employed to achieve reconstruction resolutions of
2.0x2.0 mm2 and 1.25x1.25x5 mm3 for 2D and 3D im-
ages, respectively. The ascending aorta was segmented
manually in the 2D image to obtain the corresponding
arterial input function (2D-AIF). The AIF from the 3D
image (3D-AIF) was extracted from the left-ventricular
blood pool in a mid-ventricular slice. Non-linearity ef-
fects in the 3D-AIF relative to the 2D-AIF were visual-
ized using signal intensity-time plots. To match the
signal level in both AIFs for visualization, the 3D-AIF
was scaled to the 2D-AIF by a constant factor. This scal-
ing factor was computed as the ratio of mean signal in-
tensities in the last 4 time frames of the 2D-AIF and the
3D-AIF [13–15]. Scaling was only applied for
visualization purposes, but not for the signal to concen-
tration conversion discussed below.
Contrast-to-noise ratio analysis
The left-ventricular myocardium was manually seg-
mented in eight slices of the 3D data for low and high
dose. Voxel-wise signal intensity-time curves were ex-
tracted to compute contrast-to-noise ratio (CNR) maps
at low and high dose. CNR was defined as [35]
Fig. 1 Dual-sequence diagram and corresponding ECG curve. The 3D perfusion scan is triggered to end systole with a saturation delay of 150 ms
between saturation pulse (SAT) and k-space centre. The 2D-AIF images are acquired in the aorta during diastole with a 30 ms saturation delay. 2D
image timing can be adapted to a diastolic time frame. Alternatively, for stress imaging, the 2D sequence can be run immediately after the
R-peak before the 3D perfusion scan
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CNR ¼ SNRt;max−SNRt;base ¼ St;max−St;base
σbase
: ð2Þ
In this equation, St,max and St,base are the signal inten-
sities at time points of maximum contrast enhancement
and baseline. The noise level σbase is given by the stand-
ard deviation of the signal at baseline in all myocardial
signal intensity-time curves. Example myocardial signal
intensity-time curves and CNR maps were visualized
and average whole-heart CNR values at low and high
dose were compared.
Signal intensity to concentration conversion
Average myocardial signal intensity-time curves were
calculated in six circumferential sectors in eight slices of
the 3D scan for myocardial blood flow (MBF) estima-
tion. Signal intensity was converted to CA concentration
using the signal model [9, 36]
S ¼ S0

1−expð−R1⋅TSATÞ

⋅an−1 þ

1−expð−R1⋅TRÞ

⋅
1−an−1
1−a
 
;
ð3Þ
with a ¼ cosα⋅expð−R1⋅TRÞ. TSAT is the saturation delay,
TR the repetition time, α the flip angle, n the number of
profiles between acquisition start and k-space centre and
R1 = 1/T1. S0 is a scaling factor proportional to the equi-
librium magnetization. In a first step, S0 was estimated
using the baseline signal and literature T1 values for the
left-ventricular blood pool (1200 ms) and myocardial tis-
sue (870 ms), respectively [30]. Using S0, which remains
constant during the experiment, T1 was calculated for
each time frame of the dynamic contrast-enhanced
image. Finally, T1 values were inserted into equation (1)
and the concentration c(t) was calculated for each time
frame t.
Myocardial blood flow quantification
The relationship between the concentration AIF cAIF(t)
and the myocardial concentration-time curves cMYO(t)
can be expressed by a convolution [37],
cMYOðtÞ ¼ RFðtÞ⊗cAIFðtÞ; ð4Þ
where
RF tð Þ ¼ F⋅R tð Þ ð5Þ
is the flow-weighted impulse response, F the estimate of
MBF and R(t) a monotonically decaying function with
R(t=0) = 1. MBF quantification was performed using
Fermi model deconvolution [9], i.e. the impulse response
in equation (4) was approximated by a Fermi function,
RFðtÞ ¼ F⋅ 1þ β1þ β⋅eαt ; ð6Þ
with fitting parameters α, β, F. The quantification pro-
cedure comprised multiple steps. First, cAIF(t) was re-
placed by a gamma-variate function [38] to extract the
first-pass AIF only [39]. Second, the temporal shift in
bolus arrival time between the AIF and the myocardium
was determined. The AIF was time-shifted by 0 to 6 s in
steps of 0.5 s followed by Fermi deconvolution fitting.
The temporal shift with smallest corresponding fitting
error was then selected as the bolus arrival time shift, as
suggested in [40]. The median of all regional time shifts
in a dataset was used as a global time shift [40]. MBF
quantification was performed for the low and high dose
perfusion data using cAIF(t) from the 2D-AIF and the
3D-AIF, respectively.
Statistical analysis
Statistical significance between low and high dose CNR
results and estimated MBF using 2D- and 3D-AIFs was
assessed on a per-subject basis (N = 10). The two-tailed
Fig. 2 Typical 2D and 3D perfusion scan planning. The 2D-AIF acquisition was planned in the ascending aorta in transversal orientation. The
survey scan was used as a basis and a stack of black-blood spin-echo images was included to determine the optimal slice location in feet-head
direction. Short-axis 3D scans were planned based on a 3-chamber cine scan. 16 slices of 5 mm thickness from apex to base were reconstructed.
Field-of-view and phase-encode directions were adjusted individually to avoid fold-over artefacts
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paired Student’s t-test with p < 0.05 significance level
was used for all evaluations. Bonferroni correction was
applied for the statistical analysis of MBF estimates,
where multiple t-tests of the same groups were
performed.
Results
The signal intensity for different concentrations of con-
trast agent in phantoms is plotted in Fig. 3. The satur-
ation delays correspond to those used in-vivo for 2D
(30 ms) and 3D imaging (150 ms). At low concentra-
tions, signal intensity increases linearly with concentra-
tion. At higher concentrations linearity no longer holds,
which is seen above 1 and 2 mmol/l contrast agent con-
centration for saturation delays of 150 and 30 ms,
respectively.
Example images of the 2D-AIF and 3D acquisitions
are presented in Fig. 4 for peak contrast enhancement in
the right ventricle, left ventricle and myocardium. Signal
intensities in the 2D and 3D images are increased at
high dose when compared to low dose data, as shown in
Fig. 4e, f.
Figure 5 displays a comparison of in-vivo AIFs from
one volunteer at low and high dose. Due to non-linearity
between signal and concentration, the 3D-AIF shows a
reduced signal enhancement during peak contrast bolus.
Average myocardial signal intensity-time curves from
three different slices and voxel-wise contrast-to-noise ra-
tio (CNR) maps from eight slices are shown in Fig. 6. In
this volunteer, mean CNR at high dose was 5.23 ± 0.97,
while mean CNR at low dose was 2.02 ± 0.88.
Mean CNR per volunteer and the overall CNR ratio
are summarized in Fig. 7. Average CNR and standard
deviation across volunteers was 5.34 ± 0.87 at high dose
and 2.16 ± 0.47 at low dose. The average CNR was sig-
nificantly higher at high dose compared to low dose (p <
0.001) with a mean CNR ratio of 2.55 ± 0.54.
Example myocardial blood flow (MBF) estimation re-
sults are displayed in Fig. 8. The four subplots were gen-
erated by quantifying low and high dose data using both
the 2D-AIF and the 3D-AIF. Bull’s eye plots indicate
MBF estimates in eight slices on concentric circles from
the most apical slice in the centre to the base outside.
The myocardium was divided into six angular sectors
yielding anterior, anterolateral, posterolateral, posterior,
posteroseptal, and anteroseptal segments. Mean MBF es-
timates and standard deviations in this volunteer at low
dose were 1.17 ± 0.33 and 1.07 ± 0.31 ml/g/min when
quantified using the 2D-AIF and the 3D-AIF, respect-
ively. Corresponding high dose values were 1.17 ± 0.12
and 2.65 ± 0.31 ml/g/min. Variation of MBF estimates at
low dose was 29 % of the mean MBF estimate using
both AIFs, while standard deviations at high dose were
12 % (3D-AIF) and 10 % (2D-AIF) for this volunteer.
MBF estimates were more homogeneous across angular
sectors and slices at high dose than at low dose.
Figure 9 shows mean estimates of MBF and standard
deviations across the study population and average
intra-volunteer MBF variation using 3D-AIF and 2D-AIF
at low and high dose. Mean low dose MBF estimates
quantified using the 3D-AIF and 2D-AIF were 0.92 ±
0.29 and 0.95 ± 0.23 ml/g/min, respectively. Values at
high dose were 1.57 ± 0.51 ml/g/min (3D-AIF) and 0.98
± 0.24 ml/g/min (2D-AIF). Per-subject mean MBF esti-
mates were significantly different between quantification
using 2D-AIF and 3D-AIF at high dose, while there was
no significant difference at low dose. When comparing
low and high dose on a per-subject basis, no significant
difference was found employing 2D-AIF-derived mean
MBF estimates. On the other hand, there was a signifi-
cant difference between low and high dose quantification
using the 3D-AIF. Mean relative intra-volunteer vari-
ation of MBF estimates is presented in Fig. 9b. Relative
variation for each volunteer was calculated as the stand-
ard deviation of the 48 regional MBF estimates normal-
ised by the mean MBF value and expressed in percent.
Mean variation in MBF estimates was 33.7 ± 10.4 % for
the 3D-AIF and 31.3 ± 9.1 % for the 2D-AIF at low dose.
Fig. 3 Measured phantom signal intensity vs. contrast agent
concentration. Signal intensity vs. phantom CA concentration was
measured for 2D and 3D saturation (SAT) delays used in-vivo.
Corresponding T1 values calculated using equation (1) and baseline
T1 = 1200 ms are shown alongside. Approximate peak concentrations
at low and high dose are indicated by arrows. For low enough CA
concentration, the linearity to the signal intensity is approximately
valid (dashed red line). Non-linearity starts at concentrations of 1 and
2 mmol/l for saturation delays of 150 and 30 ms, respectively
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Fig. 4 In-vivo 2D and 3D image examples at low and high dose. a, b Cardiac region of interest from five ventricular slices (apex to base) of the
3D images at peak contrast enhancement in the right ventricle, left ventricle and myocardium for low and high dose. c, d Low and high dose 2D
images at the same time points. Grayscale values in low and high dose images are individually scaled to the peak values in the left ventricle
(a, b) and ascending aorta (c, d), respectively. e Enlarged myocardial region of interest for 3 slices at peak myocardial enhancement, as indicated
by the dashed boxes in (a, b). f Close-up of ascending and descending aorta at peak blood pool enhancement in the 2D-AIF images (dashed
boxes in (c, d))
Fig. 5 Comparison of in-vivo 2D-AIF and 3D-AIF at low and high dose. 2D-AIF vs. scaled 3D-AIF at (a) low and (b) high dose. The 3D-AIF was
scaled by the average signal intensity ratio in the last four time points. Arrows highlight signal distortion of the 3D-AIF due to non-linearity
between signal intensity and concentration
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Using the high dose data, intra-volunteer MBF variation
reduced to 24.6 ± 8.7 % using the 3D-AIF and 20.3 ±
6.1 % with the 2D-AIF. Variation of MBF estimates was
significantly different between low and high dose for the
2D-AIF, but not for the 3D-AIF. Moreover, the differ-
ence in MBF variation between 2D- and 3D-AIF for both
doses was not significant.
Discussion
In this study a dual-sequence approach for high-
resolution quantitative 3D first-pass myocardial perfu-
sion CMR has been presented. By using interleaved 2D
and 3D acquisitions in each heartbeat, sequence timing
for blood pool and tissue enhancement were separately
adjustable. By comparing image sets acquired during
high and low contrast agent dose administration, it was
shown that high dose imaging yields increased CNR.
Furthermore, if saturation delays are properly optimized,
the proposed acquisition scheme allows for accurate
measurement of the AIF. Non-linearity of the AIF
around its peak is avoided if the saturation delay is
Fig. 6 Myocardial signal intensity-time curves and CNR maps. a, b Example myocardial signal intensity vs. time curves at (a) low and (b) high
dose. The curves show the mean signal from three different slices. c, d Voxel-wise myocardial contrast-to-noise ratio (CNR) maps for eight
segmented slices between apex and base. CNR maps were oriented as indicated (inset). Slice numbers in (a, b) correspond to those in (c, d). High
dose data shows more pronounced contrast enhancement and higher CNR values than low dose data. Mean CNR and standard deviations were
2.02 ± 0.88 and 5.23 ± 0.97 for low and high dose, respectively
Fig. 7 Average CNR per volunteer and CNR ratio. Mean myocardial
CNR values at low and high dose for all volunteers. Data points
corresponding to the same volunteer are connected. Mean CNR
ratio and standard deviation across the study population are plotted
on the same scale as CNR values. Statistical significance is
indicated (*** = p < 0.001)
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sufficiently short such that the signal intensity remains
proportional to contrast agent concentration.
The image acquisition framework employed for scan
interleaving allowed for independent planning of the in-
dividual scans. A stack of short-axis slices covering the
entire left ventricle was used for 3D imaging [20, 22].
The 2D-AIF scan was planned as a transverse slice out-
side the 3D volume through the ascending aorta [41].
This approach prevented additional saturation in the 3D
imaging region and thus facilitated signal intensity to
concentration conversion. By using equal flip angles,
repetition and echo times for the 2D and 3D imaging
Fig. 8 Example in-vivo myocardial blood flow (MBF) estimation results. Bull’s eye plots from low dose (a, b) and high dose (c, d) rest myocardial
perfusion imaging in one volunteer. Eight slices were quantified using average myocardial curves in six angular sectors (inset). Quantification was
performed using the 3D-AIF (a, c) and the 2D-AIF (b, d) as input functions. Numbers underneath indicate mean ± standard deviation of MBF
estimates. Homogeneous MBF distribution across slices and angular segments is observed at high dose using the 2D-AIF
Fig. 9 Myocardial blood flow quantification summary over all volunteers. a Mean and standard deviation of MBF estimates across the study
population using the 2D-AIF and 3D-AIF for quantification at low and high dose. b Relative intra-volunteer mean and standard deviation of
variation of MBF estimates for all four quantification datasets. Variation of MBF estimates was determined as the standard deviation of the 48
regional MBF estimates (8 slices, 6 sectors) within a volunteer, normalised by the mean MBF. Statistical significance is reported (n.s. = not
significant; * = p < 0.05)
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modules, signal intensity differences mainly depended
on different saturation delays. A similar approach using
mid-ventricular 2D slice location [42] was rejected be-
cause of partial saturation of the 3D signal by the 2D se-
quence, yielding more complicated signal to
concentration conversion. Furthermore, 2D imaging is
more reliable than a pencil-beam probe acquisition [43],
which is prone to inter-scan motion leading to partial
volume effects.
A high contrast agent dose of 0.1 mmol/kg b.w. was
compared to a low dose of a quarter of this amount.
While the high dose 3D-AIF exhibited strong non-
linearity effects, the quarter dose was just below the
threshold of 0.03 mmol/kg suggested for MBF quantifi-
cation with only minor non-linearity effects [5]. The
small difference between 2D-AIF and 3D-AIF at low
dose supports previous findings. Nevertheless, high dose
3D images had significantly higher CNR values than low
dose images, with a 2.6-fold gain in CNR on average.
Imaging experiments were performed on a 1.5 T MR
system. However, the proposed protocol is readily ap-
plicable at 3 T, which is expected to further enhance
CNR [44, 45].
Conversion of signal intensity to contrast agent con-
centration was performed using the signal model. In
contrast to scaling of multiple AIFs to each other by a
constant [6], signal model based conversion implicitly
corrects for sequence parameter differences and the dif-
ferent dimensionality of the images by means of the
scaling factor S0 in equation (3). Therefore, no
normalization of the 2D to the 3D image is required.
The signal model employed did not account for the effi-
ciency of the WET saturation pulse train and thus per-
fect saturation was assumed. However, inefficient
saturation might lead to additional errors in quantified
MBF estimates, especially if saturation efficiency exceeds
1 [46]. MBF quantification was performed using Fermi
model deconvolution, since it is a widespread and well-
accepted model for first-pass perfusion analysis [47].
Furthermore, comparisons with other quantification
methods revealed that Fermi deconvolution is more ro-
bust to noise [48, 49] and not inferior to other methods
[50].
Estimates of MBF were computed using the 2D-AIF
and the 3D-AIF as blood pool inputs, respectively. The
small myocardial CNR at low dose caused large intra-
volunteer variation of mean MBF estimates using both
AIFs. At high dose, quantification using the 3D-AIF data
yielded lower intra-volunteer, but even larger inter-
volunteer variation of perfusion estimates. In this case,
non-linearity effects compromised signal intensity to
concentration conversion of the AIF, which resulted in
global MBF estimation offsets. On the other hand, the
superior myocardial CNR reduced variations between
myocardial regions. Quantification using the 2D-AIF at
high dose yielded smallest intra-subject variations of
MBF estimates.
In order to compare low and high dose imaging, equal
sequence parameters were chosen for both low and high
contrast agent dose in this study. In a clinical setting,
however, the dose is usually fixed and the sequence pa-
rameters are optimized accordingly. Given the low noise
level in the 2D-AIF at high dose in all volunteers, the
optimal saturation delay for 2D imaging at a contrast
agent dose of 0.1 mmol/kg b.w. is below the 30 ms
chosen for this study. In principle, the saturation delay
can be arbitrarily short as long as the blood pool CNR is
high enough. If the 2D sequence is run with a very short
saturation delay, it can be acquired right after the R-
peak before onset of systolic flow in the aorta. This was
not possible in this study, since the saturation delay of
30 ms shifts the 2D acquisition in time and introduces a
risk of contamination of the signal by the large inflow ef-
fects in systole [33].
Short examination times and applicability during
pharmacological stress are key criteria for clinical feasi-
bility of a myocardial perfusion CMR protocol. In con-
trast to dual-bolus imaging, dual-sequence methods
enable acquisition of multiple images after a single bolus
of contrast agent. This makes the proposed acquisition
scheme compatible with established clinical protocols in
terms of examination time. The temporal resolution was
one 2D/3D image pair per heartbeat. Since heart rates
can significantly increase during stress, acquisition dur-
ing systole and early diastole is advisable. 3D imaging
was triggered to end systole, where the myocardium was
contracted and relatively quiescent. In addition to the
thicker myocardial wall compared to diastolic imaging,
measurement in systole is also favourable in terms of
image quality and artefacts [27]. 2D images were ac-
quired in diastole after aortic valve closure to suppress
inflow effects [33]. On average over all volunteers, 2D/
3D acquisition ended 700 ms after the R-peak enabling
heart rates of up to 86 min−1. At the higher heart rates
as expected during stress, and with the shortened 2D
saturation delay recommended at high dose, 2D acquisi-
tion can be performed directly after the R-peak. At the
same time the 3D acquisition window needs to be re-
duced to avoid motion induced image artefacts by short-
ening TR. While relatively long TRs of 2–2.2 ms were
chosen in the present study, optimization of sequences
timing allows TRs of 1.8–1.9 ms, hence enabling acquisi-
tion windows of 215–270 ms for 2x2x10 mm3 resolution
depending on the field-of-view. For clinical stress im-
aging, it may be necessary to trade some spatial reso-
lution to reduce the acquisition window further, as
demonstrated previously for 2.3x2.3x10 mm3 voxel size
[17, 21]. With sequence modifications as described
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above, and assuming an end-systolic trigger delay of
300 ms as well as 2/3 of the profiles acquired after that
trigger delay, acquisition ends earlier than 500 ms after
the R-peak. Accordingly and with the proposed modifi-
cations, the sequence is compatible with heart rates of at
least 120 min−1. Furthermore, the saturation delay for
3D imaging is also freely adjustable, which again relaxes
timing constraints.
Conclusions
Interleaving 2D imaging for arterial input function as-
sessment enables improved 3D myocardial perfusion im-
aging at high contrast agent dose. Short magnetization
preparation times in 2D-AIF imaging allow for accurate
input function sampling with only minor signal to con-
centration non-linearity. 3D CMR timing can be opti-
mized to deliver high contrast-to-noise ratio regardless
of non-linearity in the blood pool, yielding increased
myocardial contrast and more robust myocardial blood
flow estimates.
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